Apogee Therapeutics Inc (NASDAQ: APGE) is -21.77% lower on its value in year-to-date trading and has touched a low of $29.10 and a high of $72.29 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APGE stock was last observed hovering at around $31.43 in the last trading session, with the day’s gains setting it 4.01%.
Currently trading at $35.44, the stock is 2.88% and -10.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing 12.76% at the moment leaves the stock -23.29% off its SMA200. APGE registered -15.09% loss for a year compared to 6-month loss of -26.78%.
The stock witnessed a -12.45% gain in the last 1 month and extending the period to 3 months gives it a -23.19%, and is 16.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.43% over the week and 7.43% over the month.
Distance from 52-week low is 21.79% and -50.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.11%).
The EPS is expected to shrink by -47.74% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 45.99M, and float is at 36.93M with Short Float at 22.53%.
The top institutional shareholder in the company is VR ADVISER, LLC with over 8.49 million shares valued at $334.21 million. The investor’s holdings represent 15.0284 of the APGE Shares outstanding. As of 2024-06-30, the second largest holder is RTW INVESTMENTS, LP with 2.71 million shares valued at $106.72 million to account for 4.7989 of the shares outstanding. The other top investors are BRAIDWELL LP which holds 2.39 million shares representing 4.2326 and valued at over $94.13 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 3.7474 of the shares totaling 2.12 million with a market value of $83.34 million.
Apogee Therapeutics Inc (APGE) Insider Activity
Apogee Therapeutics Inc disclosed in a document filed with the SEC on Feb 05 ’25 that Dambkowski Carl (Chief Medical Officer) sold a total of 3,520 shares of the company’s common stock. The trade occurred on Feb 05 ’25 and was made at $40.69 per share for $0.14 million. Following the transaction, the insider now directly holds 0.25 million shares of the APGE stock.
Still, SEC filings show that on Feb 05 ’25, HENDERSON MICHAEL THOMAS (Chief Executive Officer) disposed off 15,000 shares at an average price of $40.58 for $0.61 million. The insider now directly holds 1,302,987 shares of Apogee Therapeutics Inc (APGE).
